drugset / Trial / NCT05856643
Single-arm, Open-label Clinical Study of SZ011 in the Treatment of Ovarian Epithelial Carcinoma
Phase 0
Recruiting
12 enrolled
Shantou University Medical College
Guangdong ProCapZoom Biosciences Co., Ltd. · collab
NaSingle-groupOpen-labelTreatment
Summary
This study was a single-center, open-label, investigator-initiated clinical trial (IIT) to observe and investigate the clinical safety and efficacy of SZ011 in the treatment of ovarian epithelial carcinoma
Timeline
- Start
- 2024-08-13
- Primary completion
- 2025-06-01
- Completion
- 2025-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SZ011 CAR-NK | Cell therapy | 5e+06 cells | Other |
| Subject | SZ011 CAR-NK | Cell therapy | 1e+08 cells | Other |
| Subject | SZ011 CAR-NK | Cell therapy | 2e+08 cells | Other |
| Subject | SZ011 CAR-NK | Cell therapy | 5e+08 cells | Other |